Roger Hardy Purchases 25,000 Shares of Kits Eyecare (TSE:KITS) Stock

Kits Eyecare Ltd (TSE:KITS) Director Roger Hardy acquired 25,000 shares of Kits Eyecare stock in a transaction dated Thursday, May 7th. The stock was purchased at an average price of C$11.37 per share, with a total value of C$284,250.00. Following the completion of the purchase, the director directly owned 4,093,727 shares of the company’s stock, valued at C$46,545,675.99. The trade was a 0.61% increase in their position.

Roger Hardy also recently made the following trade(s):

• On Thursday, May 7th, Roger Hardy bought 10,000 shares of Kits Eyecare stock. The stock was purchased at an average price of C$11.36 per share, for a total transaction of C$113,600.00.

Kits Eyecare Price Performance

Kits Eyecare stock traded up C$0.45 on Monday, reaching C$12.15. 76,486 shares of the stock were exchanged, compared to its average volume of 116,650. Kits Eyecare Ltd has a twelve month low of C$11.12 and a twelve month high of C$22.56. The firm has a market cap of C$412.98 million, a price-to-earnings ratio of 135.00 and a beta of 0.46.

Kits Eyecare (TSE:KITS) last issued its quarterly earnings results on Wednesday, May 6th. The company reported C$0.06 earnings per share (EPS) for the quarter. The business had revenue of C$57.47 million during the quarter.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. ATB Cormark Capital Markets cut their price target on Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating for the company in a report on Thursday. Stifel Nicolaus dropped their target price on shares of Kits Eyecare from C$24.00 to C$21.00 and set a “buy” rating on the stock in a research report on Thursday. Canaccord Genuity Group cut their target price on shares of Kits Eyecare from C$23.00 to C$22.00 and set a “buy” rating for the company in a research note on Thursday. Finally, Desjardins reduced their price target on shares of Kits Eyecare from C$25.00 to C$23.00 and set a “buy” rating for the company in a report on Thursday. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Kits Eyecare presently has an average rating of “Buy” and a consensus target price of C$20.69.

Kits Eyecare Company Profile

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.